HSBC DIS.CERT. 12/24 AMD/ DE000HG98RS7 /
04/10/2024 21:35:58 | Chg.+0.190 | Bid21:59:50 | Ask21:59:50 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
36.060EUR | +0.53% | 36.030 Bid Size: 5,000 |
36.080 Ask Size: 5,000 |
ADVANCED MIC.DEV. D... | - - | 30/12/2024 | Call |
GlobeNewswire
01/09
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire
27/08
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire
27/08
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire
26/08
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...
GlobeNewswire
23/08
AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular ...
GlobeNewswire
21/08
AMD 2023-24 Corporate Responsibility Report: Advancing Sustainability, Collaboration and Inclusion
GlobeNewswire
20/08
FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facil...
GlobeNewswire
20/08
Gamescom 2024 - HP Elevates the Gaming World through Customizable Solutions for a Personalized Playe...
GlobeNewswire
19/08
AMD to Significantly Expand Data Center AI Systems Capabilities with Acquisition of Hyperscale Solut...
GlobeNewswire
16/08
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
14/08
Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corp...